Lorber M, Samuel D, Amlot P, Panayi G S
Rheumatology Unit, United Medical School, Guy's Hospital, London, UK.
Clin Exp Immunol. 1988 Feb;71(2):275-80.
Immune complexes from rheumatoid arthritis (RA IC) and Hodgkin's disease (HD IC) sera were separated on an anti-C3g affinity column and their ability to stimulate the production of IgM and IgM RF by normal and RA B lymphocytes tested in a culture system in vitro. RA IC stimulated IgM production of which up to 91.3% had IgM RF activity. HD IC were incapable of stimulating the production of IgM and IgM RF. The stimulation of IgM and IgM RF production by RA IC required de novo protein synthesis. Both RA IC and HD IC were capable of significantly inhibiting (from 47.6 to 72.0%) pokeweed mitogen (PWM)-induced and goat F(ab)2 antihuman mu-induced B lymphocyte proliferation. Thus it is proposed that IC present in human pathological sera may regulate immunoglobulin production by an effect on B lymphocyte proliferation while some may, in addition, be capable of inducing IgM RF production from such cells.
从类风湿性关节炎(RA IC)和霍奇金病(HD IC)血清中提取的免疫复合物在抗C3g亲和柱上进行分离,并在体外培养系统中测试其刺激正常和RA B淋巴细胞产生IgM和IgM RF的能力。RA IC刺激IgM产生,其中高达91.3%具有IgM RF活性。HD IC无法刺激IgM和IgM RF的产生。RA IC刺激IgM和IgM RF产生需要从头合成蛋白质。RA IC和HD IC均能显著抑制(从47.6%至72.0%)商陆有丝分裂原(PWM)诱导的以及山羊F(ab)2抗人μ诱导的B淋巴细胞增殖。因此,有人提出,人类病理血清中存在的免疫复合物可能通过影响B淋巴细胞增殖来调节免疫球蛋白的产生,而有些免疫复合物可能还能够诱导此类细胞产生IgM RF。